BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26867903)

  • 1. How to not miss alveolar echinococcosis in hepatic lesions suspicious for cholangiocellular carcinoma.
    Mueller J; Stojkovic M; Berger AK; Rosenberger KD; Schlett CL; Kauczor HU; Junghanss T; Weber TF
    Abdom Radiol (NY); 2016 Feb; 41(2):221-30. PubMed ID: 26867903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis between hepatic alveolar echinococcosis and intrahepatic cholangiocarcinoma with conventional ultrasound and contrast-enhanced ultrasound.
    Wa ZC; Du T; Li XF; Xu HQ; Suo-Ang QC; Chen LD; Hu HT; Wang W; Lu MD
    BMC Med Imaging; 2020 Aug; 20(1):101. PubMed ID: 32854653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation between hepatic alveolar echinococcosis and primary hepatic malignancy with diffusion-weighted magnetic resonance imaging.
    Sade R; Kantarci M; Ogul H; Gundogdu B; Aydınlı B
    Diagn Interv Imaging; 2018 Mar; 99(3):169-177. PubMed ID: 29110943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
    Tsunematsu S; Chuma M; Kamiyama T; Miyamoto N; Yabusaki S; Hatanaka K; Mitsuhashi T; Kamachi H; Yokoo H; Kakisaka T; Tsuruga Y; Orimo T; Wakayama K; Ito J; Sato F; Terashita K; Nakai M; Tsukuda Y; Sho T; Suda G; Morikawa K; Natsuizaka M; Nakanishi M; Ogawa K; Taketomi A; Matsuno Y; Sakamoto N
    Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alveolar echinococcosis: correlation of imaging type with PNM stage and diameter of lesions.
    Wang J; Xing Y; Ren B; Xie WD; Wen H; Liu WY
    Chin Med J (Engl); 2011 Sep; 124(18):2824-8. PubMed ID: 22167824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma.
    Ma X; Liu L; Fang J; Rao S; Lv L; Zeng M; Shi Y; Yang C
    Cancer Imaging; 2020 Jun; 20(1):40. PubMed ID: 32576283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal of a computed tomography classification for hepatic alveolar echinococcosis.
    Graeter T; Kratzer W; Oeztuerk S; Haenle MM; Mason RA; Hillenbrand A; Kull T; Barth TF; Kern P; Gruener B
    World J Gastroenterol; 2016 Apr; 22(13):3621-31. PubMed ID: 27053854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CT appearances for differentiating of peripheral, mass-forming cholangiocarcinoma and liver meatastases from colorectal adenocarcinoma.
    Apisarnthanarak P; Pansri C; Maungsomboon K; Thamtorawat S
    J Med Assoc Thai; 2014 Apr; 97(4):415-22. PubMed ID: 24964684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Another case of hepatic alveolar echinococcosis?
    Wang T; Yang X; Wang W
    Asian J Surg; 2020 Nov; 43(11):1119-1120. PubMed ID: 32893118
    [No Abstract]   [Full Text] [Related]  

  • 10. [Imaging analysis of 79 cases of hepatic echinococcosis].
    Jun-Hu B; Yong-Hai Z; Xiu-Min H; Yao-Dong L; Yong-Xing D
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2019 Feb; 30(6):674-677. PubMed ID: 30891983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.
    Galassi M; Iavarone M; Rossi S; Bota S; Vavassori S; Rosa L; Leoni S; Venerandi L; Marinelli S; Sangiovanni A; Veronese L; Fraquelli M; Granito A; Golfieri R; Colombo M; Bolondi L; Piscaglia F
    Liver Int; 2013 May; 33(5):771-9. PubMed ID: 23445369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis.
    Park HS; Lee JM; Kim SH; Jeong JY; Kim YJ; Lee KH; Choi SH; Han JK; Choi BI
    AJR Am J Roentgenol; 2006 Aug; 187(2):445-53. PubMed ID: 16861550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma.
    Asayama Y; Yoshimitsu K; Irie H; Tajima T; Nishie A; Hirakawa M; Nakayama T; Kakihara D; Taketomi A; Aishima S; Honda H
    Radiology; 2006 Jan; 238(1):150-5. PubMed ID: 16304089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    Kim SJ; Lee JM; Han JK; Kim KH; Lee JY; Choi BI
    AJR Am J Roentgenol; 2007 Dec; 189(6):1428-34. PubMed ID: 18029881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers.
    Xu J; Igarashi S; Sasaki M; Matsubara T; Yoneda N; Kozaka K; Ikeda H; Kim J; Yu E; Matsui O; Nakanuma Y
    Liver Int; 2012 Aug; 32(7):1156-64. PubMed ID: 22417172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alveolar echinococcosis of the liver: diffusion-weighted MRI findings and potential role in lesion characterisation.
    Becce F; Pomoni A; Uldry E; Halkic N; Yan P; Meuli R; Schmidt S
    Eur J Radiol; 2014 Apr; 83(4):625-31. PubMed ID: 24457140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
    Teefey SA; Hildeboldt CC; Dehdashti F; Siegel BA; Peters MG; Heiken JP; Brown JJ; McFarland EG; Middleton WD; Balfe DM; Ritter JH
    Radiology; 2003 Feb; 226(2):533-42. PubMed ID: 12563151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholangiocarcinomas mimicking other lesions.
    Adam SZ; Parthasarathy S; Miller FH
    Abdom Imaging; 2015 Oct; 40(7):2345-54. PubMed ID: 26088342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
    Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK
    Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical value of dual-time point 18F-FDG PET/CT for differentiating extrahepatic cholangiocarcinoma from benign disease.
    Choi EK; Yoo IeR; Kim SH; O JH; Choi WH; Na SJ; Park SY
    Clin Nucl Med; 2013 Mar; 38(3):e106-11. PubMed ID: 23354026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.